Terms: = Lymphoma AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV AND Prognosis
2 results:
1. Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
Georgi TW; Kurch L; Franke GN; Jentzsch M; Schwind S; Perez-Fernandez C; Petermann N; Merz M; Metzeler K; Borte G; Hoffmann S; Herling M; Denecke T; Kluge R; Sabri O; Platzbecker U; Vučinić V
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6131-6138. PubMed ID: 36662305
[TBL] [Abstract] [Full Text] [Related]
2. Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.
Furth C; Steffen IG; Amthauer H; Ruf J; Misch D; Schönberger S; Kobe C; Denecke T; Stöver B; Hautzel H; Henze G; Hundsdoerfer P
J Clin Oncol; 2009 Sep; 27(26):4385-91. PubMed ID: 19667276
[TBL] [Abstract] [Full Text] [Related]